-+ 0.00%
-+ 0.00%
-+ 0.00%

Contineum Therapeutics Q2 EPS $(0.40) Beats $(0.48) Estimate

Benzinga·07/30/2026 20:22:10
Listen to the news
Contineum Therapeutics (NASDAQ:CTNM) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.48) by 16.67 percent. This is a 35.48 percent increase over losses of $(0.62) per share from the same period last year.